Senior Vice President, Corporate Development and Strategy
Vince Stoyanov joined Advancion in May 2021 and is responsible for leading the Company’s corporate development activities including mergers and acquisitions (M&A), integrations and strategic partnerships. Prior to Advancion, he served as Head of Global Business Development for the Life Sciences sector of MilliporeSigma. He led the global business development function for the $9 billion Life Sciences business of Merck KGaA (MilliporeSigma in U.S. and Canada), including the full spectrum of M&A growth opportunities. Prior to Merck, Stoyanov spent nine years at Agilent Technologies, Inc. where he helped lead their long-range biopharma enterprise strategy spanning cell biology, bioprocessing, contract manufacturing and enterprise lab services.
Stoyanov holds a bachelor’s degree in mathematics and economics from Colgate University and a master’s in business administration, marketing and entrepreneurial management from The Wharton School of the University of Pennsylvania.